Application of recombinant leptin to pancreatic cancer cells in vitro resulted in a significant increase in the phosphorylation of AKT,in both the murine Panc02 as well as the human Panc1 suggesting that the short form of the receptor was functional in these cells. The gene discussed is AKT1; the disease is familial pancreatic carcinoma.